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Abstract  
 
Objective  
Patients with comorbid cancer and dementia have poorer outcomes than those 
without dementia. We observe oncology teams managing patients with dementia and 
memory loss and explore these patients’ needs and experiences of out-patient 
cancer services. 
 
Methods  
A single site investigation of case study design to examine practices in four clinics 
using multi-methods of data collection; retrospective note review, observation, 
interviews and recorded consultations. A framework analytic approach identifies 
themes within and across cases. 
 
Results 
Thirty-three clinical encounters with patients with memory loss were observed. Ten 
consultations were audio-recorded and 16 individuals interviewed (n=6 patients-carer 
dyads, n=1 lone patient, n=5 staff). Medical records were reviewed for 338 cases. 
Cancer referrals did not document memory health, so clinicians rely on patient/carer 
disclosure to identify patients with memory problems. In practice the problem often 
remains hidden. Treating teams who do become aware of memory difficulties are 
unsure how to support patients, but marked memory loss can limit treatment options 
and preclude radical intent. Carers are key facilitators of successful cancer 
consultations and management. Their support needs are largely unrecognised. 
 
Conclusions 
Training that educates cancer teams on how to identify and support individuals with 
memory problems before and during treatment and recognise the carer role may 
facilitate complex cancer care and help reduce inequalities of outcomes. 
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Background  
 
Both cancer and dementia are primarily diseases of older people. Almost two thirds 
of cancers are diagnosed in those aged 65 and over [1] and one in 14 of this 
population are affected by dementia [2]. An ageing population means oncology 
teams are treating an increasing number of patients who present with comorbid 
cancer and dementia (CCD) [3,4].  
 
Data from US cancer registries suggest that the prevalence of CCD for patients aged 
68 and over is between 5 and 10% for the most common cancers: equivalent UK 
data is sparse. Cancer patients with dementia have an increased all-cause and 
cancer-specific mortality rate compared to those without dementia, and significantly 
poorer survival rates [4,5]. Inequity of outcomes is likely to be a function of later 
diagnosis [5–7], less aggressive treatments [6,8,9], a higher rate of complications 
related to treatment [6,9] and other confounding health factors. The reasons 
underlying these epidemiological observations are speculative. 
 
Recent health and social policy aims to improve the care of patients with dementia 
and reduce inequalities in their health outcomes [10–13]. These documents broadly 
recommend assessment of dementia, staff awareness and training and 
individualised care plans that encompass carer involvement and dementia-friendly 
environments. The extent to which dementia guidelines are relevant to in the delivery 
of cancer treatment is unknown.  
 
One challenge to excellent cancer care is the inherent complexity of dementia. The 
term encompasses a range of conditions that progressively impair cognitive function; 
typically presenting as memory difficulties and problematic behavioural and 
emotional change. Little is known about the complex care needs of people with CCD 
and their family carers [14]. There is also a population with mild cognitive impairment 
(MCI) [15] who, though not diagnosed with dementia, have memory loss and 
additional supportive care needs.  
 
The study aims to explore the experiences of patients with dementia and MCI in 
accessing out-patient cancer treatment services and observe their management by 
oncology teams, paying particular attention to factors that may underlie inequities in 
medical outcomes of these vulnerable people. 
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Methods  
An exploratory qualitative investigation of case study design. A case was the 
management of memory loss in a person with self-identified memory loss attending 
an out-patient clinic for cancer management. Case study was useful to examine this 
complex and sensitive topic, where the aim was to access the unspoken and tacitly 
understood [16]. This approach enabled the use of multi-methods of data collection 
to understand the complexities of the everyday work within a cancer centre from the 
perspectives of patient, clinical and wider hospital staff [17,18].  
 
Approval was granted by NHS ethics committee reference 14/WA/1030.  
 
Setting 
 
Practices were observed across four outpatient clinics at a single UK cancer centre. 
Clinics were identified as those most likely to be treating people with memory loss by 
a cancer service manager and a dementia care nurse: a urology follow-up clinic; a 
clinic for patients receiving chemotherapy for breast cancer; two treatment review 
clinics supporting patients undergoing radiotherapy. Clinicians, clinic nurses and 
nurse specialists were typically present at the breast and urology clinics. The review 
clinics were radiographer-led with specialist input for complex treatment sites. 
 
Participants  
All patients were approached for participation who were 18 years or older, receiving 
cancer treatment and identified as having memory problem (as judged by clinic staff 
and agreed by the patient).  
The recruitment process followed ethical principles for conducting research involving 
people with dementia and cognitively impaired [19,20] (flow diagram in Appendix 1.) 
In brief, a clinician gave patients written and verbal information about the study and 
introduced those interested to the researcher. If the researcher had reasonable 
doubts that the patient lacked the capacity to give informed consent, at this point or 
any other, then study activity stopped and a Mental Capacity Assessment was 
arranged. If a patient was deemed to lack capacity, a family member/carer or close 
friend was approached to become a personal consultee. The Mental Capacity Act 
(2005), defines the consultee as a person who knows the patient well, someone who 
is interested in the individual’s welfare and who can be consulted about the 
prospective participant’s wishes and feelings about participation, if the person had 
capacity.   
The clinic team gave consent to take part in study observations. The audio-recording 
of clinic consultations required both the patient and clinicians’ consent.  
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All carers accompanying participants were invited to accompany the patient 
throughout the study. 
 
Key staff members and all patient participants were invited to subsequent interview 
at a convenient place and time.  
 
Data collection methods  A retrospective review of all available electronic and paper-based medical 
records to estimate the prevalence of dementia during a four month period;   Non-participant observation of patient consultations over a four month period. 
Extensive field notes captured practice within the clinics and interactions between 
individuals;   During observation interviews with staff members after the consultations to 
understand management decisions and social actions.   After-observation interviews with patients and their carers to explore what is 
experienced as facilitative of cancer treatment, care compliance and self-care. A 
cognitive screening test that is sensitive to early dementia, the Addenbrooke’s 
Cognitive Examination (ACE-III) [21], was administered by the trained researcher 
prior to interview. Given reported deficiencies in clinical assessment of memory 
health, this tool was used to provide a standardised indication of cognitive 
function. 
 
Data analysis 
 
The analytic process was inductive and informed by Wolcott's framework for 
qualitative data analysis. Verbatim interviews, clinical consultations and field notes 
were coded and categorised for each case independently by RM and NC. Themes 
were then identified within each case and members of the research team (RB, NC, 
MK, JH) agreed those cross-cutting all cases and developed a thematic framework 
[22]. NC then used the framework to structure data summaries within case then 
across case [23]. Because of the small numbers of patients and staff who took part 
from each clinic, analysis is reported here at the level of the themes cross-cutting the 
cases, to protect the anonymity of individuals.  
 
Results        
Of the 338 clinic attendees between 01 December 2013 and 01 April 2014 (head and 
neck cancer n=84, colorectal n=55, breast n=75, prostate n=124), one patient had a 
diagnosis of dementia documented in their records.  
 
Thirty clinics were observed between October 2014 to February 2015 (breast n=10, 
urology n=13, radiotherapy review n=7). The twenty staff who agreed to take part in 
observations identified four patients with a diagnosis of dementia and 23 patients 
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with MCI. In total, we observed 33 clinical encounters between staff and patients with 
memory loss. Four patients were not due to return to clinic within the study 
timeframe and one patient died before their appointment. Of the remaining 22 
potential participants, consent was gained to audio-record 10 clinical consultations 
(n=8 with patient and carer, n=2 with patient).  
Our sample comprised three women with breast cancer and seven men – four 
diagnosed with prostate cancer, two with head and neck cancers and one with a 
pelvic malignancy. Three of these patients had a diagnosis of dementia. 
 
Five of the patient carer dyads and one lone patient agreed to be interviewed. 
Total ACE-III scores for the patients were 91, 85, 74, 66 and 40, with one participant 
failing to complete the assessment. Scores below 88 are suspicious of dementia 
[18]: normative data have been reported as a score of 95.4 [24].  Interviews were 
conducted with five staff members. 
 
The problem of memory loss and dementia in the cancer clinic was captured by four 
core themes: memory and the cancer consultation; staff attitudes; management 
approach; carer role. Findings from each theme are summarised (Table 1). Within 
each theme there was evidence of the veiling of memory loss, which will be the focus 
of the findings reported here [S denotes staff member, P patient, C carer and F field 
note.] 
 
 
Memory and the cancer clinic consultation: setting the scene  
 
The subject of memory was often notable by its absence from clinical encounters. 
The basic problem was stated as: 
 
S22 (doctor): If they have got memory issues and they don’t tell us, we don’t 
know. I guess that dementia patients have it the whole time, so a lot of them 
will hide it and know how to hide it ...  
 
Identification of a memory problem in a consultation was dependent upon patient 
disclosure or evidence of a memory difficulty:  
 
P3: ... I said my memory’s – you’ll have to excuse me ‘cos (nurse) said 
something and I couldn’t remember - and she said oh, you know, we can help 
you there, you know, we’ve got a (specialist dementia nurse)…  
 
But, memory is important in patient-cancer clinician consultations. Clinicians need 
patients to give details of their medical history, cancer symptoms, previous therapies 
and treatment side effects:  
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S13 (doctor) Just run it past me again where the, where the worst bits are 
where pain is concerned you say the 
P6: at the bottom of the spine 
S13: right down at the bottom? 
P6: yes and down this leg 
S13: down that leg, [pause] now this scan is a year old or more so whether it 
is going to help us 
P6: because I, I went a couple of weeks ago 
C5: what? 
P6: didn't I 
C5: no darling 
P6: are you sure? 
C5: no 
S13: this scan is two years old. 
 
Veracity was actively sought from the carer. However, this rarely prompted 
discussion of the underlying memory issue. At interview, two patients mentioned the 
first enquiry about their memory in the cancer clinic related to participation in this 
study. If the carer did not know the patient well, then marked memory loss acted as a 
barrier to successful consultation: 
 
S9 (doctor) asks him how he is feeling, and if he has any pains, he says he 
can’t remember how he feels. The only information the carer has on this 
patient is that he is a wanderer …. S9 said the appointment was fruitless, he 
couldn’t work out how the patient was feeling, he was asymptomatic and no 
notes had been sent over. (F 8.1.2015) 
 
Patients were found to underplay the importance and extent of memory problems in 
their cancer consultations. For example, S9 (doctor) offers to write things down for a 
patient who was 'confused with all his appointments', but he 'refused and assured 
the doctor he understood and was happy with things' (F 20.11.2014)  
 
At interview, patients expressed satisfaction with their cancer treatment and care and 
none suggested a need for improvement of the management of memory loss in 
clinic: 
 
P2: If you need anything they have been really helpful. They have put me, put 
me right on what needs to be done. 
 
 
Staff attitude to memory problems 
 
Similar numbers of people with memory problems were identified in each of the 
clinics. However, staff associated memory problems with older age. S8 (doctor) 
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explained recruitment would be difficult because 'this is a chemotherapy clinic, the 
patient’s aren’t going to be old.’ (F 2.9.2014)  
 
Identifying memory loss was difficult. ‘At 12.40, S22 (doctor) comes out and says he 
is ok, meaning that he doesn’t have memory problems. I decide to wait until the 
consultation is over to discuss further. At 13.10 he comes back out of the 
consultation and says the patient does have memory problems.' (F 11.12.2014) 
 
The focus in the clinics was on cancer treatment to the extent that staff did not 
actively seek to identify memory problems. This was particularly so when they were 
unsure there was any benefit to doing so and were aware memory was a sensitive 
topic. 'S13 (doctor) asked me what is the benefit of referring patients to the memory 
clinic, what is the memory clinic going to do? Confirm they have a memory problem? 
Can they help them? No, they can’t cure them. He thinks the memory clinic must be 
inundated with people going to them for help.' (F 11.12.2014) 
 
 
Management approach to cancer in people with dementia 
 
Staff in the clinics were witnessed using different techniques to aid recall in people 
with memory problems. For example, offering practice in important self-care 
activities: 
 
S17: Shall I show you this mouthwash then? So there’s a blue box and a 
white box 
P8: yep 
S17: and then you’ve got lots of these little, um, little tubes. So you need to 
take one of the white ones and one of the blue ones 
P8: yep. 
 
They sought information from alternative sources when patients could not recall 
clinical facts: 
 
P3: Something like that I think. I’m awful sorry, I thought I put (medicine bottle) 
in (my bag) 
S1: that’s alright, don’t worry. I’ll um, I can ring them, it’s okay, don’t worry. 
 
They also sought support from other services, for example when changing 
medication regimes: 
 
P4: Well one’s bigger than the other two see (talking about steroid tablets) 
S22 er, I-, I tell you what I’ll organise it through your GP. 
C3: Yeah. 
S22 Safest thing to do. 
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However, to receive complex cancer treatment and services the patient had to be 
'reliable' and have someone at home who could monitor for treatment side effects: 
 
S22 (doctor): if they are not reliable and they miss treatments, the treatment 
(radiotherapy) becomes less effective and so the marginal benefit they get 
goes then anyway ... if you have got umm a person with reduced mental 
capacity living on their own then the safety of giving chemotherapy is a risk.  
 
 
One of the clinics was actively working to improve the support people with memory 
problems undergo treatment. 'S18 explains to me that she is the designated 
dementia link for the department and that she sits on a working group that is looking 
into introducing a biographical tool such as the ‘This is Me’ [25]. This will help staff to 
be more person-centred in their approach and work more closely with the family or 
friend.' (F 25.11.2014). 
 
 
Role of carer in cancer treatment 
 
Away from the cancer centre, during interview, patients described being dependent 
on their carer for both cognitive support and practical help with cancer management:  
 
P5: I used to go originally on my own – but the reason (daughter) comes with 
me is because I don’t always remember what he says ... So somebody 
accompanying, somebody in there to remember in case I forget, which I do 
forget, as you know. 
 
At the cancer centre, patients often allowed carers to speak and take decisions on 
their behalf: 
 
S13 (doctor): so you have got your prescription, the (oral chemotherapy) is 
prescribed on the computer. 
C5: right. 
S13: and I shall just drop a note to your GP to ask them if they can arrange for 
you to have a Marie Curie nurse on call now and again if you need one. 
C5: ok that is fine thank you I appreciate that. 
 
When asked questions the patient might either check their response with the carer or 
look to the carer to answer: 
 
S25: Are you taking any nutritional supplements at the moment as well? 
P8: Um… 
C7: He’s taking Ensure, a few drinks. 
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S25: Are they the milky ones or juicy ones? 
C7: Milky. 
 
The carer’s compensation for their partner's impairment seemed unconscious, but 
may have been influenced by known patient sensitivity to exposure of their memory 
loss. One patient was witnessed to become angry when his daughter disclosed his 
memory problems: 
C4: Just his memory’s going a bit that’s all. 
S13: Yes. 
P5: Oi! 
C4: [Laughs] He told me not to say nothing. 
P5: I am having some memory loss, yes, I admit that.  
S13: Has it, has it, has it changed much over the, the last few months do you 
think? 
C4: I think so yeah. I think that it, the last… 
P5: I told you I’d shut you outside (this consultation) if you don’t shut your 
mouth. 
 
Clinicians were content to conduct consultations with the carer in the decision 
making role. Some commented that they may not be aware when someone had a 
memory problem because of a carer taking a lead role: 
 
S20 (support worker): I think (memory loss is) something we don’t see lots 
and lots, or maybe it is there but obviously because they’ve got relatives and, 
you know, people with them, then, then that kind of disguises it… a little 
bit. ...So maybe we’re not as aware as we probably should be sometimes. 
Although carers played a central role in facilitating cancer treatment when the patient 
had a memory problem or dementia, they did not seek support for themselves and 
clinicians were not found to enquire about their needs. The potential for interaction 
between cancer treatments and patient’s symptoms of dementia, and the 
accompanying additional demands on the carer, were not considered, with the 
exception of one recorded consultation where the adverse consequences of opioid 
medication for pain were outlined: 
 
S9 (doctor): For some patients who are a little bit prone to it, they can worsen 
confusion as well. So just watch out for that kind of thing. And if you do notice 
that he’s excessively drowsy or confused then bear in mind that it may be 
these that are the culprit. Of course you can take them off and then that will 
ease off… 
 
 
Table 1 Summary of theme findings 
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Discussion     
The problem of memory loss was found to be veiled in cancer clinic consultations. It 
was undisclosed or played down by patients, compensated for by carers and often 
unidentified by staff.  
  
Veiled memory issues 
 
Our review of medical records revealed why it is difficult for staff to identify people 
with a diagnosis of dementia – referrals to specialist cancer services do not provide 
this information. Clinicians therefore rely upon noticing the signs of memory loss or, 
more typically, upon patient/carer disclosure. Barriers to patient disclosure reported 
in the literature include resistance to acknowledge unpleasant effects of dementia, 
considering memory irrelevant to cancer and concern that disclosure may adversely 
affect treatment decisions [26,27]. 
 
Routine assessment of cognitive function before treatment is fundamental if cancer 
clinicians are to provide support that enables the best (complex) treatments safely. 
Some clinicians expressed uncertainty as to the benefits of identification of memory 
loss problems and, when aware of memory problems, were uncertain what to do to 
support the patient. In this context, dementia awareness training is relevant to all 
cancer clinicians [29]. This study did not include observation of the actual 
administration of treatments. Further research is now needed to examine the 
process of consent preceding and during treatment [30], which seeks to find out how 
staff can best identify the impacts of cognitive loss to create person-centred care 
plans that do not make assumptions about compliance with treatments [29].  
 
The carer  
 
Carers were key to successful cancer treatment and side-effect management. They 
provided physical support, such as navigating patients to and through clinics, but 
also provided cognitive support that enabled productive consultations. They gathered 
information on behalf of the patient and acted as the reliable messenger between 
patient and clinician. This role was crucial as the volume of information that modern 
oncology entails was considerable. 
 
Carers are individuals in their own right. Their role was largely unrecognised and 
their support needs hidden and unaddressed. This was partly a consequence of the 
(conscious or unconscious) compensating behaviours they adopted to veil memory 
loss. 
 
Knowledge of the mental and physical health of cancer carers is an identified gap in 
the literature and constitutes an important area for further research [31]. More 
broadly, carer’s perspective on cancer services should be actively sought in future 
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studies, given their key role identified by this study in cancer treatment of people with 
memory loss.  
 
Limitations  
 
This study explored patient experience of four out-patient clinics at a single centre. 
Further work is needed to test the transferability of findings to other settings and 
cancer populations.  
 
The study was designed to identify patients with memory loss irrespective of 
causation (as currently differentiating between memory loss due to underlying 
pathology versus cancer treatment is not possible), and we assumed benefit in 
examining practical management irrespective of cause. That these people were 
difficult for staff to identify, and participants had to agree they were experiencing 
memory loss to participate, suggest this is a sub-set of all those clinic attendees. As 
the recruitment process was initiated by clinicians, we do not know how many of the 
22 potential participants identified were invited to take part in the study, or who was 
approached but declined.  
 
The proportion of cancer patients attending the clinics with a diagnosis of dementia 
was smaller than might be expected from cohort studies [5,9]. This suggests that 
explanation of the inequality in outcomes in cancer treatment for those with dementia 
compared to those without lies beyond the cancer clinic and may, in part, be 
explained by referral decisions, which also need to be explored.  
 
Conclusion  
It is known that patients with CCD receive less treatment and experience more 
complications from treatment than patients without dementia. Our study suggests 
three areas that could have a positive effect on these inequalities. Routine cognitive 
assessment to identify cancer patients with memory problems, dementia awareness 
training for the cancer team  to help them support people with memory problems to 
undergo complex therapeutic regimes safely and strengthening support of carers 
who enable the treatment of cancer in someone with dementia. 
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Table 1 
Memory & 
the cancer 
consultation 
Clinicians rely on carers and patient self-report of memory difficulties. 
Patients can underplay the importance of memory and resist support.  
 
Staff 
attitudes 
Staff expect people presenting with memory problems to be elderly. 
Identification of problems was difficult and the value in doing so was 
questioned. 
Management 
approach 
Clinicians who are aware of memory problems can adapt their practices 
to enable a person-centred approach. A 'reliable' patient and a supportive 
carer was suggested as a prerequisite for complex cancer treatment. 
Carer role Patients were aware of the key role carers play in consultations, allowing 
them to speak and decide on their behalf – sometimes obscuring memory 
problems. The cognitive support and physical work done by carers 
seemed to be taken for granted by clinicians. 
 
 
 
 
 
